(PharmaNewsWire.Com, August 10, 2019 ) The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent. In the coming years, the Contrast Injectors Market is expected to witness the highest growth rate in the Asia-Pacific region.
The high growth in the region can be attributed to the rising approvals for various contrast agents in Asia-Pacific countries, developing markets, and the growing presence of international players in this region. In addition, the availability of government support for research, high healthcare expenditures in APAC countries, rising aging population, and increasing cancer incidences are expected to support the growth of the Asia-Pacific contrast injector market.
Market Dynamics
+ Drivers
+ Large Number of Approvals for Contrast Agents + Increasing Number of Public and Private Diagnostic Centers
On the basis of product, the contrast injector market is categorized into injector systems, consumables, and accessories. In 2016, the consumables segment is estimated to account for the largest share of the contrast injector market. This growth is mainly attributed to the recurring use of consumables in diagnostic procedures to maintain hygienic conditions. The injector systems segment is further divided into CT injector systems, MRI injector systems, and angiography injector systems. In 2016, the CT injector systems segment is expected to command the largest share of the market.
The MRI injector systems segment is expected to grow at the highest CAGR during the forecast period. The consumables segment is further divided into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). In 2016, the injector heads segment is estimated to account for the largest share of the consumables market. The injector heads segment is further categorized into single head injectors, dual head injectors, and syringeless injectors. The single head injectors segment is expected to command the largest share of the market, in 2016. The syringeless injectors segment is projected to grow at the highest CAGR during the forecast period.
On the basis of application, the contrast injector market is segmented into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to account for the largest share of the global market in 2016. Factors such as the increasing use of contrast agents in various diagnostic procedures/centers are expected to drive the contrast injectors market for radiology applications. The interventional cardiology segment is expected to grow at the highest CAGR during the forecast period.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
